HH signaling as a regulator of pancreatic cancer was first described over a decade ago, when SHH ligand was found to be expressed in a majority of pancreatic tumor cell lines and human patients [17,121,122]. The gene discussed is SHH; the disease is familial pancreatic carcinoma.